Back

Transcription Factor RUNX1 Regulates Coagulation Factor XIII-A (F13A1): Decreased Platelet-Megakaryocyte F13A1 Expression and Clot Contraction in RUNX1 Haplodeficiency

Del Carpio-Cano, F.; Songdej, N.; Guan, L.; Mao, G.; Goldfinger, L. E.; Wurtzel, J. G. T.; Lee, K.; Lambert, M. P.; Poncz, M.; Rao, A. K.

2024-12-18 hematology
10.1101/2024.12.17.24318561
Show abstract

BackgroundGermline RUNX1 haplodeficiency (RHD) is associated with thrombocytopenia, platelet dysfunction and predisposition to myeloid malignancies. Platelet expression profiling of a RHD patient showed decreased F13A1, encoding for the A subunit of factor XIII, a transglutaminase that cross-links fibrin and induces clot stabilization. FXIII-A is synthesized by hematopoietic cells, megakaryocytes and monocytes. AimsTo understand RUNX1 regulation of F13A1 expression in platelet/megakaryocyte and the mechanisms and consequences of decreased F13A1 in RHD. MethodsWe performed studies in platelets, HEL cells and human CD34+ cell-derived megakaryocytes including on clot contraction in cells following small inhibitor (si)RNA knockdown (KD) of RUNX1 or F13A1. ResultsPlatelet F13A1 mRNA and protein were decreased in our index patient and in two siblings from an unrelated family with RHD. Platelet-driven clot contraction was decreased in the patient and affected daughter. Promoter studies in HEL cells showed that RUNX1 regulates F13A1 transcription; RUNX1 overexpression increased and (si)RNA RUNX1 KD reduced F13A1 promoter activity and protein. Following RUNX1 or F13A1 KD clot contraction by HEL cells was decreased as were FXIII-A surface expression, myosin light chain phosphorylation and PAC1 binding upon activation. F13A1 expression and clot contraction were impaired on RUNX1 downregulation in human megakaryocytes. ConclusionsRUNX1 regulates platelet-megakaryocyte F13A1 expression, which is decreased in RHD, reflecting regulation of a coagulation protein by a hematopoietic transcription factor. Platelet and megakaryocyte clot contraction is decreased in RHD, related to multiple impaired mechanisms including F13A1 expression, myosin phosphorylation and IIb{beta}3 activation. Scientific category - Platelets and thrombopoiesis EssentialsO_LIRUNX1 regulates expression of FXIII-A chain (F13A1) in megakaryocytes (MK) and platelets. C_LIO_LIPlatelet and MK F13A1 expression and clot contraction are decreased in RUNX1 deficiency. C_LIO_LIMK clot contraction, myosin phosphorylation and PAC1-binding are impaired in F13A1 deficiency. C_LIO_LIDefective clot contraction in RHD arises from defects in multiple platelet-MK mechanisms. C_LI

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Blood
based on 14 papers
Top 0.1%
23.1%
2
Blood Advances
based on 16 papers
Top 0.1%
12.9%
3
British Journal of Haematology
based on 12 papers
Top 0.2%
8.7%
4
Leukemia
based on 11 papers
Top 0.3%
6.1%
50% of probability mass above
5
Scientific Reports
based on 701 papers
Top 35%
5.2%
6
PLOS ONE
based on 1737 papers
Top 75%
3.4%
7
Journal of Thrombosis and Haemostasis
based on 10 papers
Top 0.2%
3.2%
8
Atherosclerosis
based on 16 papers
Top 1%
2.8%
9
Biomedicines
based on 21 papers
Top 0.6%
2.7%
10
Frontiers in Immunology
based on 140 papers
Top 4%
2.0%
11
Journal of Clinical Investigation
based on 50 papers
Top 1%
2.0%
12
JCI Insight
based on 63 papers
Top 3%
1.8%
13
eLife
based on 262 papers
Top 15%
1.8%
14
Science Advances
based on 52 papers
Top 2%
1.4%
15
Nature Communications
based on 483 papers
Top 33%
1.4%
16
Journal of Clinical Medicine
based on 77 papers
Top 13%
0.9%
17
Cell
based on 28 papers
Top 2%
0.9%
18
Annals of the Rheumatic Diseases
based on 23 papers
Top 1.0%
0.9%
19
The American Journal of Human Genetics
based on 77 papers
Top 6%
0.9%
20
Journal of Clinical Immunology
based on 11 papers
Top 0.5%
0.9%
21
Signal Transduction and Targeted Therapy
based on 10 papers
Top 0.7%
0.9%
22
PLOS Computational Biology
based on 141 papers
Top 8%
0.9%
23
Hypertension
based on 20 papers
Top 3%
0.8%
24
BMJ Nutrition, Prevention & Health
based on 10 papers
Top 2%
0.8%
25
The Journal of Immunology
based on 19 papers
Top 2%
0.8%
26
Frontiers in Medicine
based on 99 papers
Top 19%
0.8%
27
Journal of Infection
based on 64 papers
Top 7%
0.8%
28
Computational and Structural Biotechnology Journal
based on 14 papers
Top 2%
0.8%